# Imipramine Pamoate

NDC: 0054-0274
Generic name: Imipramine Pamoate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20100419

FDA application: ANDA091099

## Active ingredients

- IMIPRAMINE PAMOATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0274"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0274
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e780825-2a66-41fd-a04c-78fa7c4df05e